MoonLake Immunotherapeutics
The Vice President of Market Access & Pricing will lead the development and execution of the U.S. market access and pricing strategy, overseeing formulary placement, payer engagement, contracting, gross-to-net forecasting, and patient services infrastructure. The role also drives global access initiatives, builds the market access organization, and partners with cross‑functional teams to ensure compliant, scalable launch and post‑launch capabilities.
MoonLake (MoonLake TX) Immunotherapeutics is a clinical-stage biopharmaceutical company developing next‑level immunotherapies to elevate patient care. The company focuses on translating cutting‑edge science into clinical candidates and advancing those therapies through clinical development. MoonLake aims to bring novel immune‑modulating treatments to patients and partners with academic and industry collaborators to accelerate development and access.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MoonLake Immunotherapeutics.
MoonLake Immunotherapeutics didn’t post a salary, so this is our estimate from similar listings.
6% above the average for this role
Senior Director, Market Access Pricing & Contracting
NewAmsterdam Pharma
Vice President, Market Access
Mirum Pharmaceuticals
Associate Director, Pricing Strategy & Access Analytics
Amylyx Pharmaceuticals
Vice President, US Market Access
Skyhawk Therapeutics
Senior Director, US Rare Disease Value and Access
sanofi us
VP of Access Strategy & Payer Engagement
Ocular Therapeutix